Genetic and environmental factors drive personalized medicine for Crohn’s disease
- 24 September 2018
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 128 (11) , 4758-4760
Abstract
The introduction of anti-TNF antibody therapy has changed the course of treatment for Crohn’s disease. However, the fundamental mechanism for the onset of Crohn’s disease is still unknown, and the treatment strategy for this disease remains suboptimal. The assessment of the disease phenotype based on key environmental factors and genetic background may indicate options for the personalized treatment of Crohn’s disease. In this issue of the JCI, Liu et al. show that consumption of tobacco and the mutation of ATG16L1T300A, a prevalent Crohn’s disease susceptibility allele, drive defects in cells at the bottom of the intestinal crypt, the Paneth cells. These factors may provide novel targets for personalized medicine.Keywords
This publication has 23 references indexed in Scilit:
- Interaction between smoking and ATG16L1T300A triggers Paneth cell defects in Crohn’s diseaseJournal of Clinical Investigation, 2018
- Genetics of Inflammatory Bowel DiseasesGastroenterology, 2015
- Comparison of Magnetic Resonance and Balloon Enteroscopic Examination of the Small Intestine in Patients With Crohn's DiseaseGastroenterology, 2014
- Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defenseProceedings of the National Academy of Sciences, 2014
- Genetic Variants Synthesize to Produce Paneth Cell Phenotypes That Define Subtypes of Crohn's DiseaseGastroenterology, 2014
- A Prospective Study of Long-term Intake of Dietary Fiber and Risk of Crohn's Disease and Ulcerative ColitisGastroenterology, 2013
- Paneth cells as a site of origin for intestinal inflammationNature, 2013
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseNature, 2012
- Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative ColitisAnnals of Internal Medicine, 2012
- Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitisNature, 2011